- Article metrics
- Last updated: Sun, 1 Feb 2026 9:17:24 Z
Epitope editing enables targeted immunotherapy of acute myeloid leukaemia
Access & Citations
-
- 56k
- Article Accesses
-
- 95
- Citations
Citation counts are provided by Dimensions and depend on their data availability. Counts will update daily, once available.
Online attention
- 206 tweeters
- 3 blogs
- 2 Facebook pages
- 13 news outlets
- 150 Mendeley
This article is in the 98th percentile (ranked 4,172nd) of the 368,160 tracked articles of a similar age in all journals and the 73rd percentile (ranked 270th) of the 1,032 tracked articles of a similar age in Nature
View more on Altmetric
Altmetric calculates a score based on the online attention an article receives. Each coloured thread in the circle represents a different type of online attention. The number in the centre is the Altmetric score. Social media and mainstream news media are the main sources that calculate the score. Reference managers such as Mendeley are also tracked but do not contribute to the score. Older articles often score higher because they have had more time to get noticed. To account for this, Altmetric has included the context data for other articles of a similar age.
Mentions in news and blogs
-
马吉妥昔单抗获批上市;FDA拒绝批准贝伐珠单抗眼用制剂上市
CN-Healthcare -
AML: Epitop-Editing könnte Einsatz von CAR-T-Zellen und Antikörper ermöglichen
Deutsches Ärzteblatt -
급성 골수성 백혈병의 표적 면역치료를 가능하게 하는 항원결정부위 편집(Nature)
Nature Asia -
Researchers Develop a Potential “Universal” CAR T-Cell Therapy for Blood Cancers
Cancer Currents: An NCI Cancer Research Blog
This list highlights individual mainstream news articles and blogs that cite the article. Not all news and blogs link to articles in a way that Altmetric can pick up, so they are not representative of all media. Altmetric are responsible for the curation of this list and provide updates hourly.